Medicofarma Biotech Balance Sheet Health
Financial Health criteria checks 2/6
Medicofarma Biotech has a total shareholder equity of PLN8.7M and total debt of PLN1.5M, which brings its debt-to-equity ratio to 17.4%. Its total assets and total liabilities are PLN14.7M and PLN6.0M respectively.
Key information
17.4%
Debt to equity ratio
zł1.51m
Debt
| Interest coverage ratio | n/a |
| Cash | zł12.65k |
| Equity | zł8.70m |
| Total liabilities | zł6.05m |
| Total assets | zł14.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MDB's short term assets (PLN3.1M) do not cover its short term liabilities (PLN3.7M).
Long Term Liabilities: MDB's short term assets (PLN3.1M) exceed its long term liabilities (PLN2.4M).
Debt to Equity History and Analysis
Debt Level: MDB's net debt to equity ratio (17.2%) is considered satisfactory.
Reducing Debt: MDB's debt to equity ratio has increased from 0% to 17.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDB has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MDB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.